Trial reportUrolithiasis2022
The impact of smart technology on adherence rates and fluid management in the prevention of kidney stones.
Trial report in Urolithiasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Adherence to medical management of kidney stones: A systematic review.Urolithiasis · 2026Pooled it
- Feasibility of Mini sipUrology · 2023Trial
- The association between quality of life, intensity of counseling and health literacy amongst patients with nephrolithiasis.World journal of urology · 2026Article
- The impact of a multidisciplinary clinic on patient adherence to kidney stone prevention therapy.World journal of urology · 2025Article
- Small Data Approaches to Link Faster Time Scale Engagement Dynamics with Slower Time Scale Outcomes in Biobehavioral Interventions.Chinese political science review · 2025Article
- What patients with kidney stones believe about their condition.Urolithiasis · 2024Article
- Promoting fluid intake to increase urine volume for kidney stone prevention: Protocol for a randomized controlled efficacy trial of the sipContemporary clinical trials · 2024Article
- Hydration for Adult Patients with Nephrolithiasis: Specificities and Current Recommendations.Nutrients · 2023Review
- Accuracy of a smart bottle in measuring fluid intake by American football players during pre-season training.Scientific reports · 2023Article
- Fluid intake recommendations in urolithiasis and general advice to patients without metabolic risk factors.World journal of urology · 2023Article
- Patient compliance to dietary recommendations: tips and tricks to improve compliance rates.World journal of urology · 2023Article
- UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
Smart technology (ST) can enhance chronic disease management, yet little is known about the benefits of ST on kidney stone prevention. Our aim was to prospectively evaluate the impact of ST on follow-up adherence rates and urine output (UOP) in patients with nephrolithiasis. Kidney stone patients with low UOP (< 2.5 L/24 h) were randomized into three intervention groups: (1) standard dietary/medical counseling alone (control), (2) control + smartphone fluid management application (app), and (3) control + smart water bottle (bottle). Demographics, adherence rates, kidney stone events, and 24 h urine data were collected and analyzed at baseline, 3-6, and 12 months. We randomized 111 patients (37 per group), of which 20 (55%), 8 (26%), and 10 (33%) patients completed the 12 month follow-up in the control, app, and bottle groups respectively. Control group patients were the most likely to adhere to follow-up (p = 0.004). Overall mean UOP increased by 0.4 L in each group (p < 0.05), with no difference in mean baseline 24 h UOP (1.6 L) and 12 month 24 h UOP (2.0 L) between groups (p > 0.05). Twenty-nine percent of patients achieved a daily UOP goal of > 2.5 L across the treatment groups (p < 0.001). In this prospective study, the 24 h UOP improved across all groups compared to baseline, although adherence to follow-up remained low. Furthermore, the use of ST did not further augment UOP, underscoring the importance of dietary/medical counseling for kidney stone prevention.
Indexed as
Identifiers
34115205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.